In this study, the expression of CBX7 was reduced 0.44-fold in the DCIS-HN comparison; however, we did not observe a significant decrease of E-cadherin in our preinvasive clinical samples. The gene discussed is CDH1; the disease is ductal breast carcinoma in situ.